Published November, 2006
By Roland Mertelsmann, Monika Engelhardt, Dietmar Berger, M Engelhardt, H Hen, D P Berger, R Mertelsmann and H Hena
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Rating:
Availability: Contact supplier

---

Published July, 2006
By Attilio Orazi, Dennis P. O'Malley, Daniel A. Arber and Dennis O'Malley
Publisher: Cambridge University Press
Rating:
Availability: Available

This book provides a highly illustrated overview of the diseases of the human bone marrow. It will help experienced pathologists and those in training to answer the diagnostic questions that arise during the routine analysis of bone marrow core biopsy specimens. Histologic interpretation is integrated with clinical and laboratory findings.

---

Published July, 2006
By Elizabeth A Eisenhauer, Christopher Twelves and Marc Buyse
Publisher: Oxford University Press
Rating:
Availability: Available

Phase I trials are the first step in the study of novel therapeutic approaches. They aim to identify the recommended dose, schedule and pharamcologic behaviour of new drugs, and to describe the adverse effects of treatment. This practical guide discusses the design, conduct, analysis and ethical aspects of Phase I cancer trials.

---

Published July, 2006
By Silvano Sozzani and Raffaele Badolato
Publisher: Springer (Birkhauser Verlag AG)
Series: Progress in Inflammation Research
Rating: 1.00
Availability: Available

This book deals with the description of the role of chemokines in immune response and underlines potential targets of therapeutical intervention.

---

Published May, 2006
By Ines Mader, Patrizia R F]rst-Weger, Robert M Mader, Elisabeth I Semenitz, Robert Terkola, Sabine M Wassertheurer, Patrizia R Furst-Weger, Elisabeth Nogler-Semenitz, I Mader, P R Frst-Weger and Sabine Wassertheurer
Publisher: Springer (Springer Verlag GmbH)
Rating:
Availability: Available

Paravasation von Zytostatika kann zu schwerwiegenden Zwischen- und Notfallen bei der Tumortherapie fuhren. Vordrucke fur ein Paravasate-Set, UEbersichtstabellen, Dokumentationsboegen und Patientenaufklarungen sowie eine CD-ROM liegen zur Unterstutzung fur die klinische Praxis bei.

---

Published April, 2006
By Richard C. Becker and Frederick A. Spencer
Publisher: Oxford University Press (Oxford University Press Inc)
Rating:
Availability: Available

Provides an evidence-based approach to the management of thrombotic disorders for clinicians involved in the care of patients. This book provides conceptual information on fibrinolytic and antithrombotic therapy, and the means to apply it to decision making and patient care. It focuses on management guidelines and critical pathways.

---

Published April, 2006
By Rodger L. Bick, Eugene P. Frenkel, William F. Baker, Ravi Sarode and Carolyn B. Coulam
Publisher: Cambridge University Press
Rating:
Availability: Available

This textbook describes the haematological complications of obstetrics, pregnancy and gynaecology. The etiology, pathophysiology, clinical and laboratory diagnosis and management are discussed for all disorders. The book is written by well-recognised experts in each area covered.

---

Published March, 2006
By Shamim I. Ahmad, Shamin I. Ahmad, Sandra H. Kirk, Shamim Ahmad and Sandra Kirk
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Medical Intelligence Unit
Rating:
Availability: Available

This book provides the only comprehensive treatise available on Fanconi Anemia. It gives a detailed analysis from the clinical to the molecular levels of the disorder. The book will give research students a platform for further investigation, and act as a source of information regarding experimental design.

---

Published February, 2006
By John P. Leonard and Morton Coleman
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available

In recent years a dramatic increase in knowledge of the biology of the lymphomas has been accompanied by the emergence of new treatments offering improvements in efficacy and reduction in toxicity.

---

Published February, 2006
By Jan A. Nolta
Publisher: Springer (Springer-Verlag New York Inc.)
Rating:
Availability: Available

MSC (mesenchymal stem cells) have been reported to initiate revascularization after injury, to facilitate engraftment of blood-forming stem cells, and to reduce the incidence of graft-vs.

---